Semaglutide in Boston (2026)

The best ways to get Semaglutide in Boston, Massachusetts. Compare 212 providers, compounded vs brand pricing, and local insurance.

212 Semaglutide providersCompounded from $87/moAvg ~$2,004/yr less than Wegovy self-pay

Featured Partners · Boston

Featured Semaglutide providers serving Boston

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

  1. Top pick
    7.7

    Compounded semaglutide from

    See pricing

    Get started →
  2. Compounded semaglutide from

    $79/mo

    “starting at” price

    Get started →
  3. Compounded semaglutide from

    $79/mo

    sale price

    Get started →
  4. 8.2

    Compounded semaglutide from

    $129/mo

    starting dose

    Get started →
  5. Compounded semaglutide from

    $169/mo

    12-month plan rate

    Get started →
  6. 8.1

    Compounded semaglutide from

    $200/mo

    starting dose

    Get started →
Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Getting Semaglutide in Boston

Boston is a major city in the United States, located in Massachusetts with a population of approximately 675,647. Telehealth is legal in Massachusetts, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Boston ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

Boston residents have access to both brand-name Semaglutide (Wegovy and Ozempic) and compounded Semaglutide formulations through licensed 503A compounding pharmacies[4]. Brand-name Wegovy costs $349/month through the manufacturer's self-pay program (NovoCare self-pay; list price $1,349)[3], while compounded Semaglutide from telehealth providers averages around $182/month (ongoing rate) in Massachusetts[1] — about $2,004 a year less than self-pay Wegovy. Insurance coverage for anti-obesity GLP-1s in Massachusetts varies by plan[5], and Massachusetts's adult obesity rate is approximately 25.0%[2].

For the full step-by-step process, read our how to get semaglutide online guide. To compare every low-cost route, see our cheapest way to get GLP-1s without insurance guide. If you're weighing compounded against brand-name semaglutide, our compounded vs. branded GLP-1 decision guide breaks down the evidence. Before starting, review what the clinical trials actually showed about GLP-1 side effects.

Brand Wegovy
NovoCare self-pay (list $1,349)
$349/mo
Compounded Semaglutide
Massachusetts average, ongoing rate
$182/mo
Annual savings
average vs Wegovy self-pay
$2,004

Semaglutide in Boston: The Massachusetts Numbers

Our clinic directory lists 330 weight-management/obesity-medicine clinics in Boston (312 with a public profile) — an in-person option alongside the telehealth providers above. Among the Semaglutide providers above serving Massachusetts, ongoing pricing ranges from $87 to $1695/mo. The cheapest verified ongoing compounded Semaglutide price available to Boston residents is $87/mo — verified against the provider's live pricing, not an advertised teaser. On the insured side, Massachusetts Medicaid reimbursed approximately $9,593,310 across 8,853 Semaglutide-class prescriptions in Q1 2026 (all covered indications, gross before rebates — full state series).

Local clinics with a public profile: Nikheel Kolatkar, Boston Plastic Surgery Associates, PC, Douglas Ross, Steven Shoelson, Marie Demay and 307 more.

All Semaglutide Providers Serving Boston

8.1/ 10
Partner

bmiMD

Best for: one flat compounded GLP-1 price at every dose: semaglutide $159/mo month to month, $119/mo on a 12-month plan

★★★★☆4.1/5

Editorial score · methodology

$159/mosemaglutide
$249/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →
8.1/ 10
Partner

RxSpan MD

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

★★★★☆4.1/5

Editorial score · methodology

$249/mosemaglutide
$329/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneLegitScript Verified
Get StartedRead full RxSpan MD review →
8.0/ 10
Partner

Strut Health

Best for: oral-lozenge compounded GLP-1 access

★★★★☆4/5

Editorial score · methodology

$99/mosemaglutide
“starting at” price
$149/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Strut Health review →
7.9/ 10
Partner

GobyMeds

Best for: no-membership, no-auto-renew compounded GLP-1 orders, from about $99/mo on a 3-month bundle

★★★★☆4/5

Editorial score · methodology

$169/mosemaglutide
“starting at” price
$299/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full GobyMeds review →
7.7/ 10
Partner

Live Vital

Best for: low-cost, physician-led compounded GLP-1 with peptide and hormone options

★★★★☆3.9/5

Editorial score · methodology

$130/mosemaglutide
after intro offer
$239/motirzepatide
after intro offer
CompoundedSemaglutideTirzepatideBPC-157CJC-1295 / Ipamorelin
Get StartedRead full Live Vital review →
Browse all 212 Semaglutide providers serving Boston A–Z

Semaglutide in Boston and the rest of Massachusetts

Boston shares a metro area with Providence, Rhode Island, but telehealth programs are licensed state by state. The 212 semaglutide programs on this page are the ones that list Massachusetts; semaglutide in Providence draws on Rhode Island's list instead. The statewide table is at semaglutide across Massachusetts. Compounded semaglutide starts at $87/mo for Massachusetts addresses; tirzepatide in Boston starts higher, at $126/mo.

Medicaid in Massachusetts ended its weight-loss coverage of GLP-1s, though it still covers Wegovy for heart-attack and stroke risk and MASH liver disease with prior authorization. It does cover GLP-1s for type 2 diabetes with prior authorization. Our Massachusetts Medicaid GLP-1 coverage guide has the current criteria and the appeal process. Elsewhere in Massachusetts, we publish the same breakdown for semaglutide in Worcester and semaglutide in Springfield.

Related Pages

Frequently Asked Questions

Boston residents can get Semaglutide through licensed telehealth providers that ship directly to Massachusetts addresses. Brand-name Wegovy and Ozempic can also be prescribed in-person by a local clinician and filled at a retail pharmacy; the manufacturer's own self-pay price is $349/mo (NovoCare self-pay), against a list price of $1,349/mo.
Compounded Semaglutide pricing is set at the provider level, not the city level. See the provider cards above for current monthly pricing from providers that serve Massachusetts. Brand-name Wegovy costs $349/month through the manufacturer's self-pay program (list price $1,349).
Yes. Compounded Semaglutide is legal in Massachusetts when prescribed by a licensed provider and dispensed by a 503A or 503B compounding pharmacy. Boston residents can legally receive shipments from licensed compounders located in any US state.
Insurance coverage in Boston for Semaglutide depends on your diagnosis and plan. Most insurers cover the diabetes-indicated brands (Ozempic) for type 2 diabetes, but coverage for the obesity-indicated brands (Wegovy) is much more limited and typically requires prior authorization.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Get Semaglutide Price Alerts in Boston

Be the first to know about new Semaglutide promos and providers in Boston.

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
  3. 3.NovoCare — Wegovy cash-pay and savings program— Novo Nordisk (NovoCare).
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.